Suchergebnisse - "Ram, Felix S F"

PubPharm (35)

1

Comparing the effectiveness of intranasal fentanyl spray with oral transmucosal fentanyl citrate in breakthrough pain

enthalten in: International journal of palliative nursing | 2015

von Shellard, S. | Ram, F.

2

Comparing the effectiveness of intranasal fentanyl spray with oral transmucosal fentanyl citrate in breakthrough pain

enthalten in: International journal of palliative nursing | 2015

von Shellard, S. | Ram, F.

3

Topical antibiotics for the management of bacterial keratitis : an evidence-based review of high quality randomised controlled trials

enthalten in: The British journal of ophthalmology | 2014

von McDonald, E. | Ram, F. | Patel, D. | +1

4

Topical antibiotics for the management of bacterial keratitis: an evidence-based review of high quality randomised controlled trials

enthalten in: British journal of ophthalmology | 2014

von McDonald, E. | Ram, F. | Patel, D. | +1

5

Effectiveness of Topical Antifungal Drugs in the Management of Fungal Keratitis : A Systematic Review and Meta-analysis of Randomized Controlled Trials

enthalten in: Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) | 2014

von McDonald, E. | Ram, F. | Patel, D. | +1

6

Antivirals for management of herpes zoster including ophthalmicus : a systematic review of high-quality randomized controlled trials

enthalten in: Antiviral therapy | 2012

von McDonald, E. | de Kock, J. | Ram, F.

7

Tiotropium mist inhaler for COPD increases risk of mortality compared with placebo

enthalten in: Evidence-based medicine | 2011

von Ram, F.

CommentOn: BMJ. 2011;342:d3215. - PMID 21672999

8

Tiotropium mist inhaler for COPD increases risk of mortality compared with placebo

enthalten in: Evidence based medicine | 2011

von Ram, F.

9

ACP Journal Club. Review : oral phosphodiesterase 4 inhibitors reduce exacerbations but increase adverse events in COPD

enthalten in: Annals of internal medicine | 2011

von Ram, F.

CommentOn: Cochrane Database Syst Rev. 2011;(5):CD002309. - PMID 21563134

10

Spiriva (Respimat) increases mortality by 52% in patients with COPD : time to take action

enthalten in: The New Zealand medical journal | 2011

von Ram, F.